No crucial amino acid changes in the predicted histo blood group antigen-binding sites of norovirus genotype GII.4 capsid between non-secretors and secretors origin might suggest an alternative route of infection or existence of coincidental molecules

References

1. Allen D. J., Noad R., Samuel D., Gray J. J., Roy P., Iturriza-Gómara M. 2009; Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J 6:150 [View Article][PubMed]
   [Google Scholar]
2. Bauer K. 1997; Foot-and-mouth disease as zoonosis. Arch Virol Suppl 13:(Suppl.)95–97[PubMed]
   [Google Scholar]
3. Carlsson B., Kindberg E., Buesa J., Rydell G. E., Lidón M. F., Montava R., Abu Mallouh R., Grahn A., Rodríguez-Díaz J., other authors. 2009; The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 norovirus infection. PLoS One 4:e5593 [View Article][PubMed]
   [Google Scholar]
4. Debbink K., Lindesmith L. C., Donaldson E. F., Costantini V., Beltramello M., Corti D., Swanstrom J., Lanzavecchia A., Vinjé J., Baric R. S. 2013; Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis 208:1877–1887 [View Article][PubMed]
   [Google Scholar]
5. Henry S., Mollicone R., Fernandez P., Samuelsson B., Oriol R., Larson G. 1996; Molecular basis for erythrocyte Le(a+b+) and salivary ABH partial-secretor phenotypes: expression of a FUT2 secretor allele with an A → T mutation at nucleotide 385 correlates with reduced α(1,2) fucosyltransferase activity. Glycoconj J 13:985–993 [View Article][PubMed]
   [Google Scholar]
6. Hutson A. M., Atmar R. L., Graham D. Y., Estes M. K. 2002; Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185:1335–1337 [View Article][PubMed]
   [Google Scholar]
7. Jin M., He Y., Li H., Huang P., Zhong W., Yang H., Zhang H., Tan M., Duan Z. J. 2013; Two gastroenteritis outbreaks caused by GII noroviruses: host susceptibility and HBGA phenotypes. PLoS One 8:e58605 [View Article][PubMed]
   [Google Scholar]
8. Jones M. K., Watanabe M., Zhu S., Graves C. L., Keyes L. R., Grau K. R., Gonzalez-Hernandez M. B., Iovine N. M., Wobus C. E., other authors. 2014; Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346:755–759 [View Article][PubMed]
   [Google Scholar]
9. Kelly R. J., Rouquier S., Giorgi D., Lennon G. G., Lowe J. B. 1995; Sequence and expression of a candidate for the human Secretor blood group α(1,2)fucosyltransferase gene (FUT2): homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640–4649 [View Article][PubMed]
   [Google Scholar]
10. Kindberg E., Akerlind B., Johnsen C., Knudsen J. D., Heltberg O., Larson G., Böttiger B., Svensson L. 2007; Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol 45:2720–2722 [View Article][PubMed]
    [Google Scholar]
11. Koda Y., Soejima M., Kimura H. 2001; The polymorphisms of fucosyltransferases. Leg Med (Tokyo) 3:2–14 [View Article][PubMed]
    [Google Scholar]
12. Kojima S., Kageyama T., Fukushi S., Hoshino F. B., Shinohara M., Uchida K., Natori K., Takeda N., Katayama K. 2002; Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods 100:107–114 [View Article][PubMed]
    [Google Scholar]
13. Kudo T., Iwasaki H., Nishihara S., Shinya N., Ando T., Narimatsu I., Narimatsu H. 1996; Molecular genetic analysis of the human Lewis histo-blood group system. II. Secretor gene inactivation by a novel single missense mutation A385T in Japanese nonsecretor individuals. J Biol Chem 271:9830–9837 [View Article][PubMed]
    [Google Scholar]
14. Larsson M. M., Rydell G. E. P., Grahn A., Rodriguez-Diaz J., Akerlind B., Hutson A. M., Estes M. K., Larson G., Svensson L. 2006; Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis 194:1422–1427 [View Article][PubMed]
    [Google Scholar]
15. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., Stewart P., LePendu J., Baric R. 2003; Human susceptibility and resistance to Norwalk virus infection. Nat Med 9:548–553 [View Article][PubMed]
    [Google Scholar]
16. Lindesmith L. C., Donaldson E. F., Lobue A. D., Cannon J. L., Zheng D. P., Vinje J., Baric R. S. 2008; Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 50:e31 [View Article][PubMed]
    [Google Scholar]
17. Lindesmith L. C., Beltramello M., Donaldson E. F., Corti D., Swanstrom J., Debbink K., Lanzavecchia A., Baric R. S. 2012; Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 8:e1002705 [View Article][PubMed]
    [Google Scholar]
18. Lindesmith L. C., Costantini V., Swanstrom J., Debbink K., Donaldson E. F., Vinjé J., Baric R. S. 2013; Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol 87:2803–2813 [View Article][PubMed]
    [Google Scholar]
19. Liu P., Wang X., Lee J. C., Teunis P., Hu S., Paradise H. T., Moe C. 2014; Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease. Pediatr Infect Dis J 33:e305–e309 [View Article][PubMed]
    [Google Scholar]
20. Marionneau S., Ruvoën N., Le Moullac-Vaidye B., Clement M., Cailleau-Thomas A., Ruiz-Palacois G., Huang P., Jiang X., Le Pendu J. 2002; Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122:1967–1977 [View Article][PubMed]
    [Google Scholar]
21. Rouquier S., Lowe J. B., Kelly R. J., Fertitta A. L., Lennon G. G., Giorgi D. 1995; Molecular cloning of a human genomic region containing the H blood group α(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270:4632–4639 [View Article][PubMed]
    [Google Scholar]
22. Shanker S., Choi J. M., Sankaran B., Atmar R. L., Estes M. K., Prasad B. V. V. 2011; Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol 85:8635–8645 [View Article][PubMed]
    [Google Scholar]
23. Tan M., Jin M., Xie H., Duan Z., Jiang X., Fang Z. 2008; Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 80:1296–1301 [View Article][PubMed]
    [Google Scholar]
24. Tan M., Xia M., Chen Y., Bu W., Hegde R. S., Meller J., Li X., Jiang X. 2009; Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One 4:e5058 [View Article][PubMed]
    [Google Scholar]
25. Thorven M., Grahn A., Hedlund K.-O., Johansson H., Wahlfrid C., Larson G., Svensson L. 2005; A homozygous nonsense mutation (428G → A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 79:15351–15355 [View Article][PubMed]
    [Google Scholar]
26. Yoda T., Suzuki Y., Yamazaki K., Sakon N., Kanki M., Kase T., Takahashi K., Inoue K. 2009; Application of a modified loop-mediated isothermal amplification kit for detecting norovirus genogroups I and II. J Med Virol 81:2072–2078 [View Article][PubMed]
    [Google Scholar]